NCT01005004已完成1 期
Phase I Study of the Safety and Preliminary Efficacy of Intracerebral Transplantation of HuCNS-SC® Cells for Connatal Pelizaeus-Merzbacher Disease (PMD)
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- Safety assessment through clinical neurological and MRI evaluation.
研究概览
简要总结
The purpose of this study is to determine the safety and preliminary effectiveness of human central nervous system stem cells (HuCNS-SC®) transplantation in patients with Connatal Pelizaeus-Merzbacher Disease (PMD).
详细描述
Enrolled subjects will be transplanted with HuCNS-SC cells into the brain and will receive immunosuppression for nine months. The study observation period is for one year after transplant surgery. Thereafter, subjects will be enrolled in a long-term observational follow-up study for four years.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 6 Months 至 5 Years（Child）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Confirmed clinical diagnosis of connatal PMD
- •Molecular genetic confirmation of mutation in the proteolipid protein 1 (PLP1) gene
- •MRI consistent with PMD as interpreted by a qualified neuroradiologist
排除标准
- •Other significant congenital brain abnormality not related to PMD
- •Previous participation in gene transfer or cell transplant trial
- •Presence of neurological signs and symptoms not consistent with PMD
- •Current or prior malignancy
- •Prior organ, tissue or bone marrow transplant
研究组 & 干预措施
HuCNS-SC cells
Experimental
Intracerebral implantation of HuCNS-SC via direct injection during surgery
干预措施: HuCNS-SC cells (Biological)
结局指标
主要结局
Safety assessment through clinical neurological and MRI evaluation.
时间窗: one year post transplant
次要结局
- MRI examination for post-transplant myelination(one year post transplant)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
NitiNotes' EndoZip System for the Treatment of ObesityObesityNCT03472196Nitinotes Surgical Ltd.14
招募中
1 期
Safety and Early Signs of Efficacy of IL12-L19L19.Metastatic Solid TumorAdvanced Solid TumorNCT04471987Philogen S.p.A.80
Unknown
不适用
Preliminary Evaluation of the Clinical Safety and Effectiveness of the Bionic Nerve ScaffoldPeripheral Nerve InjuriesNCT03780855Xijing Hospital10
招募中
1 期
BC008-1A Injection for Recurrent CNS WHO G4 GliomaGlioma Tumor RecurrenceGlioma, Recurrent High GradeGlioblastoma WHO Grade IVGlioblastomas (GBM)GliomaNCT06773481Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.40
进行中（未招募）
1 期
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid TumorsAdvanced Solid TumorNCT05007782Gilead Sciences304